Puma Biotechnology Correlations

PBYI Stock  USD 6.37  0.01  0.16%   
The current 90-days correlation between Puma Biotechnology and Eledon Pharmaceuticals is 0.52 (i.e., Very weak diversification). The correlation of Puma Biotechnology is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Puma Biotechnology Correlation With Market

Significant diversification

The correlation between Puma Biotechnology and DJI is 0.04 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Puma Biotechnology and DJI in the same portfolio, assuming nothing else is changed.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Puma Biotechnology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
For more detail on how to invest in Puma Stock please use our How to Invest in Puma Biotechnology guide.

Moving together with Puma Stock

  0.75ATI Allegheny TechnologiesPairCorr
  0.67ACR-PC ACRES Commercial RealtyPairCorr
  0.82MCHP Microchip TechnologyPairCorr
  0.8ACN Accenture plcPairCorr
  0.64BAC Bank of AmericaPairCorr
  0.64JPM JPMorgan ChasePairCorr
  0.61JNJ Johnson Johnson Earnings Call This WeekPairCorr
  0.68XOM Exxon Mobil Corp Aggressive PushPairCorr

Moving against Puma Stock

  0.69LIPO Lipella PharmaceuticalsPairCorr
  0.53HPQ HP IncPairCorr

Related Correlations Analysis


Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

ARCTVYGR
HUMAVYGR
HUMAARCT
HUMAELDN
TRDAALLO
SGMTHUMA
  

High negative correlations

SGMTTRDA
TRDAHUMA
TRDAELDN
TRDAARCT
TRDAVYGR
SGMTALLO

Risk-Adjusted Indicators

There is a big difference between Puma Stock performing well and Puma Biotechnology Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Puma Biotechnology's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Puma Biotechnology Corporate Management

Jeffrey LudwigChief OfficerProfile
Roger StormsSenior SalesProfile
Alvin PharmdChief OfficerProfile
Heather BlaberSenior MarketingProfile
FRAPS BScPharmacovigilance, AffairsProfile